Scholarlink

Background <p>Lung cancer is one of the most common malignant tumours, with non-small cell lung cancer (NSCLC) being the predominant type. The morbidity and mortality rates of lung cancer are increasing worldwide. The Hippo signalling pathway is one of the eight classical human cancer signalling pathways, forming a complex signalling network regulated by intracellular and extracellular signals. Under physiological conditions, it plays a crucial role in inhibiting tumor development.</p> Main text <p>Inhibition of the Hippo signalling pathway leads to abnormal activation of its downstream core components, YAP/TAZ, which in turn enhances tumor cell proliferation, invasion, and migration. Recent studies have identified numerous small-molecule inhibitors that target key proteins within the Hippo signalling pathway, which is highly important for the treatment of tumors.</p> Conclusion <p>This paper reviews the activation mechanisms of the Hippo signalling pathway, its crosstalk with other pathways, and potential therapeutic targets to provide new therapeutic avenues.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The components and regulation of the Hippo pathway and its relationships with the progression and treatment of Non-small cell lung cancer (NSCLC)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月20日

查看全文
  • Yuheng Feng,
  • Xueting Gan,
  • Xuezhu Rong,
  • Qiang Han

摘要

Background

Lung cancer is one of the most common malignant tumours, with non-small cell lung cancer (NSCLC) being the predominant type. The morbidity and mortality rates of lung cancer are increasing worldwide. The Hippo signalling pathway is one of the eight classical human cancer signalling pathways, forming a complex signalling network regulated by intracellular and extracellular signals. Under physiological conditions, it plays a crucial role in inhibiting tumor development.

Main text

Inhibition of the Hippo signalling pathway leads to abnormal activation of its downstream core components, YAP/TAZ, which in turn enhances tumor cell proliferation, invasion, and migration. Recent studies have identified numerous small-molecule inhibitors that target key proteins within the Hippo signalling pathway, which is highly important for the treatment of tumors.

Conclusion

This paper reviews the activation mechanisms of the Hippo signalling pathway, its crosstalk with other pathways, and potential therapeutic targets to provide new therapeutic avenues.